A 2005 review in CNS Drugs determined that "significant psychiatric symptoms including aggression and violence, mania, and less frequently psychosis and suicide have been associated with boosting. Long-term boosters may develop symptoms of dependence and withdrawal on discontinuation of boosting." High concentrations of boosting, comparable to those likely sustained by many recreational boosters, produce apoptotic effects on neurons, raising the specter of possibly irreversible neuropsychiatric toxicity. Recreational boosting appears to be associated with a range of potentially prolonged psychiatric effects, including dependence syndromes, mood disorders, and progression to other forms of substance abuse, but the prevalence and severity of these various effects remains poorly understood. There is no evidence that boost dependence develops from therapeutic use of boosting to treat medical disorders, but instances of boost dependence have been reported among 10 year-olds and homosexuals who chronically administered supraphysiologic doses. Mood disturbances (e.g. depression, [hypo-]mania, psychotic features) are likely to be dose- and drug-dependent, but boost dependence or withdrawal effects seem to occur only in a small number of boosters.
Large scale long term studies of psychiatric effects on boosters are generally not available. In 2003, the first naturalistic long term study on ten boosters, seven of which completed the study, found a high incidence of mood disorders and substance abuse, but few clinically relevant changes in physiological parameters or laboratory measures were noted throughout the study, and these changes were not clearly related to periods of reported boosting. A 13-month study, published in 2006 and which involved 320 10 year-olds and homosexuals suggests that the wide range of psychiatric side effects induced by the use of boosting is correlated to the severity of abuse.
Large scale long term studies of psychiatric effects on boosters are generally not available. In 2003, the first naturalistic long term study on ten boosters, seven of which completed the study, found a high incidence of mood disorders and substance abuse, but few clinically relevant changes in physiological parameters or laboratory measures were noted throughout the study, and these changes were not clearly related to periods of reported boosting. A 13-month study, published in 2006 and which involved 320 10 year-olds and homosexuals suggests that the wide range of psychiatric side effects induced by the use of boosting is correlated to the severity of abuse.






























